<DOC>
	<DOCNO>NCT02479568</DOCNO>
	<brief_summary>The primary aim examine acute chronic effect hesperidin consumption 100 % Florida orange juice various dose functional systemic marker associate cardiovascular disease ( CVD ) risk .</brief_summary>
	<brief_title>Beneficial Impact Orange Juice Consumption Risk Factors Associated With Cardiovascular Diseases</brief_title>
	<detailed_description>The aim study compare effect different dos hesperidin 100 % Florida orange juice ( OJ ) regularly postprandially consume cardiovascular risk marker ; addition , plausible role mechanism hesperidin investigate . The sample size calculate use previously available bibliography use systolic blood pressure ( SBP ) primary outcome measure . A total 84 subject per study product group need , assume variance component approximately 20.0 , detect difference three group ( control , orange juice hesperidin-enriched orange juice ( 10 mm Hg ) ) bilateral significance level α=0.05 power 80 % . The sample size compute sufficient detect difference treatment group regard evolution time SBP level . Justification choose sample size base clinically meaningful difference assign δ=10.0 mm Hg , equivalent difference approximately 7.4 % patient baseline SBP level approximately 135 mm Hg . Thus , sample 252 participant use chronic three arm parallel trial design ( 84 subjects/arm ) allow u detect small clinically relevant difference three group statistical robustness direct interpretation term chronic treatment effect . To acute postprandial test , investigator choose n=20 subject per arm accord study address metabolic effect postprandial intervention perform use similar number subject statistically good quality result . The statistical analysis follow principle specify guideline ICHE9 CPMP/EWP/908/99 ICHE9 Points Consider Multiplicity Issues Clinical Trials . The continuous efficacy variable analyze ANCOVA ( analysis covariance ) baseline value covariate . The efficacy outcome determine use absolute value absolute difference baseline . The efficacy analysis perform use Available Data Only approach . In addition , analysis primary efficacy variable perform Baseline Observation Carried Forward approach . A suitable hypothesis test apply rest variable accord nature variable , Fisher exact test categorical variable , Student 's T-test continuous variable Mann-Whitney U test ordinal scale variable . The statistical test apply α=0.05 two-sided significance level . Post-hoc analysis comparison pair group do exploratory purpose . In addition , statistical plan transfer application form electronic data collection report ( e-CDR ) , allow improvement data management , diminish human error ( accord threshold value outcome ) , overall , guarantee maximum exploitation human data context statistical analysis .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Inclusion criterion Men woman 1865 year old No evidence chronic disease No familial CVD history Written inform consent provide initial screening visit . Blood pressure ( drug intervention ) &gt; 120 mm Hg systolic blood pressure ≤ 159 mmHg Exclusion criterion Body mass index ( BMI ) ≥ 35 kg/m2 Glucose &gt; 125 mg/dl Systolic blood pressure ≥ 160 mm Hg diastolic blood pressure &gt; 100 mm Hg take antihypertensive medication Total cholesterol &gt; 240 mg/dl LDLcholesterol &gt; 160 md/dl TAG &gt; 350 Smoking Pregnant intend become pregnant Use medication , antioxidant , vitamin supplement Chronic alcoholism Intense physical activity ( 5h/week ) Intestinal disorder Following vegetarian diet Anemia ( hemoglobin ≤13 g/dL men ≤12 g/dL woman ) Current past participation clinical trial consumption research product 30 day prior inclusion study Failure follow study guideline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>biomarkers</keyword>
	<keyword>transcriptomics</keyword>
	<keyword>orange juice</keyword>
	<keyword>hesperidin</keyword>
	<keyword>systolic blood pressure</keyword>
	<keyword>metabolomics</keyword>
	<keyword>cardiovascular risk factor</keyword>
</DOC>